Literature DB >> 30565129

Immunofluorescence Microscopy to Study Endogenous TAZ in Mammalian Cells.

Nathan M Kingston1, Andrew M Tilston-Lunel1, Julia Hicks-Berthet1, Xaralabos Varelas2.   

Abstract

The transcriptional coactivator with PDZ-binding motif (TAZ), which is encoded by the WWTR1 gene, is a key transcriptional effector of the Hippo signaling pathway. TAZ function has been implicated in a variety of developmental processes and diseases, most notably in driving oncogenesis. Given that nuclear-cytoplasmic localization dynamics dictate TAZ activity, techniques for visualizing TAZ localization are critical for its study. Here we describe an immunofluorescence microscopy protocol that allows for the visualization of TAZ subcellular localization in mammalian cells, offering an approach that can aid in the analysis of TAZ regulation and function.

Entities:  

Keywords:  Hippo pathway; Immunofluorescence microscopy; TAZ; WWTR1

Mesh:

Substances:

Year:  2019        PMID: 30565129      PMCID: PMC7781096          DOI: 10.1007/978-1-4939-8910-2_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

1.  The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.

Authors:  Chen-Ying Liu; Zheng-Yu Zha; Xin Zhou; Heng Zhang; Wei Huang; Di Zhao; Tingting Li; Siew Wee Chan; Chun Jye Lim; Wanjin Hong; Shimin Zhao; Yue Xiong; Qun-Ying Lei; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2010-09-21       Impact factor: 5.157

2.  Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.

Authors:  Tobias A Beyer; Alexander Weiss; Yuliya Khomchuk; Kui Huang; Abiodun A Ogunjimi; Xaralabos Varelas; Jeffrey L Wrana
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

3.  Targeted Disruption of YAP and TAZ Impairs the Maintenance of the Adrenal Cortex.

Authors:  Adrien Levasseur; Guillaume St-Jean; Marilène Paquet; Derek Boerboom; Alexandre Boyer
Journal:  Endocrinology       Date:  2017-11-01       Impact factor: 4.736

4.  TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.

Authors:  F Kanai; P A Marignani; D Sarbassova; R Yagi; R A Hall; M Donowitz; A Hisaminato; T Fujiwara; Y Ito; L C Cantley; M B Yaffe
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

Review 5.  The emerging roles of YAP and TAZ in cancer.

Authors:  Toshiro Moroishi; Carsten Gram Hansen; Kun-Liang Guan
Journal:  Nat Rev Cancer       Date:  2015-01-16       Impact factor: 60.716

6.  The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members.

Authors:  William M Mahoney; Jeong-Ho Hong; Michael B Yaffe; Iain K G Farrance
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

7.  Hippo pathway effector Yap promotes cardiac regeneration.

Authors:  Mei Xin; Yuri Kim; Lillian B Sutherland; Masao Murakami; Xiaoxia Qi; John McAnally; Enzo R Porrello; Ahmed I Mahmoud; Wei Tan; John M Shelton; James A Richardson; Hesham A Sadek; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

8.  Yap and Taz are required for Ret-dependent urinary tract morphogenesis.

Authors:  Antoine Reginensi; Masato Hoshi; Sami Kamel Boualia; Maxime Bouchard; Sanjay Jain; Helen McNeill
Journal:  Development       Date:  2015-08-01       Impact factor: 6.868

Review 9.  YAP/TAZ at the Roots of Cancer.

Authors:  Francesca Zanconato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cancer Cell       Date:  2016-06-13       Impact factor: 31.743

10.  Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development.

Authors:  Antoine Reginensi; Rizaldy P Scott; Alex Gregorieff; Mazdak Bagherie-Lachidan; Chaeuk Chung; Dae-Sik Lim; Tony Pawson; Jeff Wrana; Helen McNeill
Journal:  PLoS Genet       Date:  2013-03-21       Impact factor: 5.917

View more
  3 in total

1.  The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF Signaling.

Authors:  Athanasios Pseftogas; Konstantinos Xanthopoulos; Theofilos Poutahidis; Chrysanthi Ainali; Dimitra Dafou; Emmanuel Panteris; Joseph G Kern; Xaralabos Varelas; Alexander Hardas; Christos Gonidas; Anastasia Tsingotjidou; Eudoxia Hatzivassiliou; George Mosialos
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

2.  Src family kinases inhibit differentiation of intestinal epithelial cells through the Hippo effector YAP1.

Authors:  Sepideh Fallah; Jean-François Beaulieu
Journal:  Biol Open       Date:  2021-11-15       Impact factor: 2.422

Review 3.  Cellular feedback dynamics and multilevel regulation driven by the hippo pathway.

Authors:  Jiwon Park; Carsten Gram Hansen
Journal:  Biochem Soc Trans       Date:  2021-08-27       Impact factor: 5.407

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.